[Comparative study of TMS-19-Q and midecamycin for respiratory tract infection by double-blind method].
D001424:Bacterial Infections / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D007933:Leucomycins / Q000627:therapeutic use*; D015644:Miocamycin / Q000031:analogs & derivatives*; D011014:Pneumonia / Q000188:drug therapy*; D011019:Pneumonia, Mycoplasma / Q000188:drug therapy
D007933:Leucomycins; D015644:Miocamycin; C026483:midecamycin; C033383:rokitamycin